As gold prices hit new records, China is quietly stockpiling massive quantities of the precious metal — far beyond official figures — as part of a de-dollarization strategy that’s reshaping global markets.

The U.S. and Switzerland have reached a trade agreement to reduce tariffs to 15%. Swiss companies have pledged $200 billion in U.S. investments by 2028, focusing on manufacturing, pharmaceuticals, and workforce development.

Investor confidence in a December rate cut has dropped to just 49% after hawkish comments from Fed officials. With policymakers divided, markets brace for either a “hawkish hold” or one final symbolic cut before the cycle ends.

U.S. and global stocks fell sharply, while Bitcoin dropped below $100,000. Investors worry that the Federal Reserve could slow its pace of interest-rate cuts, triggering a new wave of selling in technology shares.

U.S. President Donald Trump has threatened to sue the BBC for $1 billion, claiming the broadcaster distorted his Jan. 6, 2021 speech. The BBC has apologized and pulled the documentary, but the crisis of trust in global media continues to deepen.

Trump signals a possible tariff cut for India as his loyal ally Sergio Gor becomes U.S. ambassador, reshaping Washington–New Delhi trade diplomacy.

As Europe faces mounting threats from Russian and Chinese space assets, several NATO members — notably Germany, the U.K., and France — are dramatically expanding their budgets for space defense.

SoftBank Group Corp. has sold its entire $5.83 billion stake in Nvidia to finance new AI-focused ventures. This article analyzes the strategy, market impact, and risks behind Masayoshi Son’s bold move.

The United States’ decision to resume nuclear testing and launch the Minuteman III missile is seen as part of a pressure campaign on Russia amid the ongoing Ukraine conflict. However, experts caution that this move could backfire, escalating tensions and triggering a new global arms race.

China is leveraging its dominance in rare earths as a strategic tool in its geopolitical contest with the United States. But experts warn that overusing this “economic weapon” could accelerate global efforts to diversify supply chains and weaken Beijing’s long-term influence.

Pfizer wins $10 billion bidding war for Metsera, securing entry into the booming $150 billion obesity drug market and reshaping the global pharma landscape.

As Russia’s influence wanes in the Caspian Sea, Turkey and its regional partners, including Azerbaijan and Kazakhstan, are reshaping the naval balance and redefining the strategic order of this crucial region.